It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argues Sui Huang from the ...

Patients with lung adenocarcinoma – the most common type of cancer among non-smokers -- carry a specific mutation in the ...

Genetic and genomic testing guide breast cancer risk assessment and treatment, as discussed by Dr. Mark Robson at the Miami ...

In the continuing evolution of personalized medicine, a new study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with ...

Scientists compared blood from frequent, long-term donors to that of more seldom ones and saw some key genetic differences in ...

Dr. Alison Moody, a breast surgeon at Ascension Sacred Heart in Panama City, shares her advice on how to interpret the Jan. 3 ...

"Anyone with lungs can get lung cancer, yet lung cancer continues to receive less research funding compared to other cancers.

A research team has uncovered new insights into the molecular mechanisms of ADAR1, a protein that regulates ribonucleic acid (RNA) induced immune responses. Their findings could open new pathways for ...

The discovery of the high-risk cells — a subset of progenitor cells that reside in fallopian tube supportive tissue, or stroma — may pave the way for better approaches to prevent and detect high-grade ...

Zydus Hospital has introduced Next-Generation Sequencing (NGS), a molecular tool for detecting genetic mutations linked to ...

Significant progress in preclinical pipeline targeting KRAS-driven solid tumor cancers with systemic administration demonstrating robust anti-tumor and anti-metastasis activity in orthotopic mouse ...